On Tuesday, Ocugen Inc (NASDAQ: OCGN) was -4.50% drop from the session before settling in for the closing price of $1.0. A 52-week range for OCGN has been $0.51 – $1.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.82% over the past five years. When this article was written, the company’s average yearly earnings per share was at -7.50%. With a float of $286.77 million, this company’s outstanding shares have now reached $292.19 million.
Let’s look at the performance matrix of the company that is accounted for 95 employees. In terms of profitability, gross margin is 39.97%, operating margin of -1165.08%, and the pretax margin is -1197.71%.
Ocugen Inc (OCGN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ocugen Inc stocks. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.48%. The most recent insider transaction that took place on Jul 09 ’25, was worth 122,887. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 146,705 for $1.17, making the entire transaction worth $171,029.
Ocugen Inc (OCGN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.50% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
You can see what Ocugen Inc (OCGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 58.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Ocugen Inc (NASDAQ: OCGN) saw its 5-day average volume 2.91 million, a negative change from its year-to-date volume of 4.68 million. As of the previous 9 days, the stock’s Stochastic %D was 17.00%.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 56.77%, which indicates a significant increase from 5.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0690 in the past 14 days, which was lower than the 0.0724 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0240, while its 200-day Moving Average is $0.8346.
